Patient Stories: Voices of Access | Association for Accessible Medicines
ICYMI - View memorable moments and quotes from #Access2021
AAM Voices of Access: Patient Stories

Patient Stories: Voices of Access

AAM Voices of Access report

AAM’s “Voices of Access” report features patients across the country speaking about the importance of generic and biosimilar medicines in their lives. This annual publication tells the impact that accessible medicines have on everyday Americans – on their health journeys, their economic well-being and their daily lives.  
Download Report

View Interactive Report

Meet the AAM Patients

Read their story on the AAM blog:


Listen to Their Stories 

Sep 29, 2020 | Erica Klinger
Rich's Story — Generic Prescription Savings
Dec 17, 2020 | Erica Klinger
Helen's Story — She Knows She Can Rely on Biosimilars
Feb 14, 2017 | Erica Klinger
Raeanne's Story - #medswithinreach
May 22, 2021 | Erica Klinger
Michelle's Story - #medswithinreach
May 22, 2021 | Erica Klinger
McKenzie's Story - #medswithinreach
May 22, 2021 | Erica Klinger
Doug's Story - #medswithinreach
Sep 12, 2018 | Erica Klinger
Ariel Leaty - Cancer Thriver!
Dec 14, 2018 | Erica Klinger
Keon's Story
Jan 17, 2019 | Erica Klinger
Jonnie's Story
Oct 8, 2020 | Erica Klinger
Jeni's Story — Biosimilars Savings

Share Your Story

Patient stories like yours are essential as federal and state policies arise that might affect your access. Please use this form to start the conversation. 

Some prompts and helpful hints to get you started or view other patient stories:

  • “I take generic prescription drugs (or biosimilar medicine) for my…”
  • “The way I get my prescription drugs is…”
  • “Compared to before the pandemic, my savings on generics …”

AAM respects your privacy and won’t share any of your personal information without your consent.

Please wait until your video has finished uploading before you click “submit".



Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.